Advik Laboratories Ltd.
| BSE: 531686 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE537C01019 |
| BSE 00:00 | 19 Apr | 1.01 |
0 (0.00%) |
OPEN
1.01 |
HIGH
1.01 |
LOW
1.01 |
| NSE 05:30 | 01 Jan | Advik Laboratories Ltd |
| OPEN | 1.01 |
| PREVIOUS CLOSE | 1.01 |
| VOLUME | 1200 |
| 52-Week high | 1.01 |
| 52-Week low | 0.37 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Advik Laboratories Ltd. (ADVIKLABS) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 645.05 | 4.75 | 0.74 | 3211.14 |
| Dr Reddy's Labs | 5153.95 | 183.40 | 3.69 | 2937.70 |
| Cipla | 949.30 | 2.70 | 0.29 | 2318.17 |
| Aurobindo Pharma | 987.40 | 21.90 | 2.27 | 1872.74 |
| Cadila Health. | 556.05 | 28.75 | 5.45 | 1412.90 |
| Divi's Lab. | 3783.80 | -21.35 | -0.56 | 1372.71 |
| Glenmark Pharma. | 571.15 | -7.80 | -1.35 | 1354.55 |
| Alkem Lab | 2738.95 | -7.05 | -0.26 | 1264.42 |
| Alembic Pharma | 995.25 | -4.85 | -0.48 | 969.40 |
| Torrent Pharma. | 2604.75 | 9.35 | 0.36 | 938.51 |
| Gland Pharma | 2642.55 | -121.70 | -4.40 | 772.86 |
| Lupin | 1090.25 | 28.80 | 2.71 | 727.55 |
| Ipca Labs. | 2157.25 | -15.85 | -0.73 | 652.46 |
| Abbott India | 14860.60 | 158.15 | 1.08 | 592.93 |
| Fortis Health. | 208.00 | 7.50 | 3.74 | 513.33 |
| Pfizer | 5480.60 | 152.30 | 2.86 | 509.13 |
| Sanofi India | 7683.15 | -75.50 | -0.97 | 477.60 |
| Natco Pharma | 895.75 | -4.00 | -0.44 | 474.50 |
| Apollo Hospitals | 3272.85 | 117.30 | 3.72 | 470.30 |
| Granules India | 334.40 | -7.10 | -2.08 | 444.07 |
Quick Links for Advik Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
